Characterization of Residual Impurities in Gene Therapy Drug Products

Characterization of Residual
Characterization of residual impurities for gene therapy drug products is particularly challenging due to the complex nature of the final products as well as the complicated processes required to manufacture them.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Making Oral solid dosage forms with galenIQ™ - the sweet-tasting filler binder

During direct compression tablets are manufactured without pre-granulation. Excipients therefore need to be highly effective, controllable and free-flowing.
Watch Now

Proving the strategic value of patients

pmlive

On the 10th October Cello Health Insight, in association with PMGroup, will look at the value of three areas of patient research that provide that ‘must have’ understanding: mapping the patient pathway, patient motivation and the dialogue between patient and HCP.
Watch Now

Document Imaging and Medical Record Management

Lorman

Many Health Information Management departments are still prepping charts that come from all departments of a hospital system. This means that there is a potential time lag in making this critical information available to providers. The first place to start is selecting a document imaging solution for any paper being produced outside of your EMR system. But let's take this a step further. What if we move document imaging out of the HIM department and into each clinical area of a hospital?
Watch Now

A Blueprint for Translational Integrated Drug Discovery

Charles River

What does the future of your drug discovery program look like? Many industry leaders are finding themselves in uncharted waters: the science is more sophisticated than ever, producing paradigm-altering treatments. But, historically high R&D costs and low success rates has emphasized the need to identify drugs focused on translationally-relevant targets in the most cost and time efficient way.
Watch Now

Spotlight

resources